Skip to main content
OpenTrials
Completed

NCT Number: NCT01770054

Prevalence of Metabolic Syndrome in Atahualpa

A recent epidemiologic survey demonstrated a high prevalence of type 2 diabetes mellitus in Atahualpa residents. Now, the investigators attempt to evaluate the prevalence of the metabolic syndrome in adults aged 40 years or more living in this rural village of coastal Ecuador.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Metabolic Syndrome Diabetes Mellitus Endocrine System Diseases Glucose Metabolism Disorders Hyperinsulinism Insulin Resistance Metabolic Diseases Nutritional and Metabolic Diseases

Age range

40 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Center of Health

Atahualpa, Santa Elena, 0000, Ecuador

About this study

Several studies have shown that the occurrence of the metabolic syndrome is a risk factor for the development of cerebrovascular and ischemic heart disease. To evaluate the prevalence of the metabolic syndrome, we will invite all Atahualpa residents aged 40 years or more to participate in this study. For the purposes of this study we will obtain the waist circumference of all individuals, will measure their blood pressure using a standard protocol, and will take a blood sample to determine fasting glucose levels, HDL cholesterol levels, triglyceride levels, and plasma insulin levels.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Atahualpa resident aged 40 years or more

Exclusion criteria

  • non-consenting persons

Treatment and study plan

obtention of a blood sample

Other

a blood sample will be obtained to measure glucose, HDL cholesterol, triglycerides, and for genetic testing

Primary outcomes

  1. Prevalence of metabolic syndrome

    Time frame: 5 months

    determination of the metabolic syndrome in subjects aged 40 years or more

Secondary outcomes

  1. Genetic testing

    Time frame: 5 months

    Blood will be taken to evaluate the ADN pattern of this population, to compare with other Amerindian populations with a proven high prevalence of diabetes mellitus and metabolic syndrome

Other outcomes

  1. determination of the prevalence of hyperinsulinemia

    Time frame: 5 months

    plasma insulin levels will be determined

Sponsors and collaborators

Lead sponsor

Hospital Clínica Kennedy

Other

Registry information

Official study title

Evaluation of the Prevalence of Metabolic Syndrome in Atahualpa Residents Aged 40 Years or More.

Important dates

Study start
2013
Primary completion
2013
Study completion
2013
First posted
Jan 17, 2013
Registry last updated
Mar 8, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.